UiPath Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results

Core Insights - UiPath reported a revenue of $481 million for Q4 fiscal 2026, representing a 14% year-over-year increase, and an annual revenue of $1.611 billion, up 13% year-over-year [1][2] - The company achieved an Annualized Renewal Run-rate (ARR) of $1.853 billion, an 11% increase year-over-year, with a dollar-based net retention rate of 107% [1][2] - UiPath announced a new stock repurchase program authorizing the repurchase of up to $500 million of its Class A common stock following the completion of a previous $1 billion program [1][2] Financial Highlights - Q4 fiscal 2026 non-GAAP operating income was $150 million, while GAAP operating income was $80 million [1][2] - Full-year fiscal 2026 non-GAAP adjusted free cash flow was $372 million, with net cash flow from operations at $371 million [1][2] - Non-GAAP gross margin for Q4 was 86%, and for the full year, it was 85% [1][2] Business Developments - UiPath launched new agentic AI solutions for the healthcare industry, focusing on medical records summarization and claim denial prevention [2] - The company announced the acquisition of WorkFusion, enhancing its portfolio in financial crime compliance solutions [2] - UiPath joined the Agentic AI Foundation as a Gold Member to advance interoperability in agentic AI adoption [2] Market Position - UiPath was recognized as a leader in The Forrester Wave™ for Autonomous Testing Platforms, receiving top marks in several criteria [2] - The company was also named a leader in G2's 2026 Best Software Awards across five categories, highlighting its strong market presence [2] - UiPath's Screen Agent achieved a top ranking on the OSWorld-Verified benchmark for enterprise-wide agentic AI deployments [2]